Attys Seek $4M Fee For BridgeBio Board Pay Suit In Chancery
Attorneys for a BridgeBio Pharma Inc. investor are seeking a $4 million fee award for litigation in Delaware Chancery Court they say headed off a plan to pay the company's directors...To view the full article, register now.
Already a subscriber? Click here to view full article